Table 3.
Multivariable Models | Ischemic Cardiac Events | |||
---|---|---|---|---|
HR (95% CI) | P Value | χ2 | Harrell's C (95% CI) | |
Clinical model | ||||
Age | 1.046 (1.03–1.07) | 0.000 | 67.5 | 0.701 (0.658–0.744) |
Diabetes mellitus | 1.431 (0.987–2.074) | 0.059 | ||
Known CAD | 1.733 (1.158–2.593) | 0.008 | ||
ASA | 1.522 (0.970–2.389) | 0.068 | ||
Clopidogrel | 1.483 (0.978–2.247) | 0.063 | ||
Clinical+stress‐echocardiography WM | ||||
Age | 1.045 (1.025–1.065) | 0.000 | 73.5a | 0.720b (0.678–0.763) |
Diabetes mellitus | 1.383 (0.953–2.006) | 0.088 | ||
Known CAD | 1.775 (1.195–2.637) | 0.004 | ||
ASA | 1.391 (0.881–2.195) | 0.157 | ||
Clopidogrel | 1.310 (0.862–1.989) | 0.206 | ||
Reversible WM abnormality | 1.758 (1.196–2.585) | 0.004 | ||
Clinical+stress‐echocardiography MP | ||||
Age | 1.046 (1.026–1.066) | 0.000 | 76.3a | 0.723b (0.681–0.764) |
Diabetes mellitus | 1.409 (0.972–2.041) | 0.070 | ||
Known CAD | 1.810 (1.217–2.693) | 0.003 | ||
ASA | 1.339 (0.847–2.118) | 0.212 | ||
Clopidogrel | 1.299 (0.857–1.969) | 0.218 | ||
Reversible MP abnormality | 1.839 (1.275–2.652) | 0.001 | ||
Clinical+stress‐echocardiography WM and MP | ||||
Age | 1.45 (1.025–1.066) | 0.000 | 76.7a, b | 0.725b (0.683–0.766) |
Diabetes mellitus | 1.395 (0.961–2.024) | 0.080 | ||
Known CAD | 1.806 (1.215–2.684) | 0.003 | ||
ASA | 1.335 (0.843–2.111) | 0.218 | ||
Clopidogrel | 1.281 (0.844–1.944) | 0.245 | ||
Reversible MP abnormality | 1.633 (0.971–2.747) | 0.064 | ||
Reversible WM abnormalities | 1.197 (0.695–2.063) | 0.517 |
All patients with inducible WM abnormalities also had reversible MP defect. The last model (WM and MP) with both WM and MP is not significantly more accurate than the previous models with only WM or MP, while they maintain higher Harrell's C and χ2 compared with the clinical model. ASA indicates acetylsalicylic acid; CAD, coronary artery disease; HR, hazard ratio; MP, myocardial perfusion; WM, wall motion.
Means P<0.01 all compared with clinical model.
Means P<0.05.